Skip to content
Politics
Prognosis

Pfizer Covid-19 Booster Shot Set to Be Cleared for Younger Teens, NYT Reports

  • Move would expand access to protection as omicron spreads
  • Expanded clearance expected for immune-compromised kids
A Covid-19 vaccination site in Long Beach, New York, on May 13. 

A Covid-19 vaccination site in Long Beach, New York, on May 13. 

Photographer: Emily Elconin/Bloomberg
Updated on

U.S. regulators are planning to clear Pfizer Inc.’s Covid-19 booster shot for younger adolescents on Monday, expanding access at a time when researchers have found that an additional vaccine dose provides better protection against the widely circulating omicron variant.

The Food and Drug Administration is preparing to grant emergency-use authorization for people ages 12 to 15 years old to receive a third dose of the messenger RNA vaccine, which Pfizer developed with partner BioNTech SE, the New York Times reported, citing people familiar with the matter. A booster is also expected to be authorized for children ages 5 to 11 who have immune deficiencies, the newspaper said.